Peritoneal Dialysis Complication Clinical Trial
Official title:
Characteristics and Clinical Outcomes of Peritoneal Dialysis Patients
Peritoneal dialysis patients worldwide account for about 11% of the global dialysis population. The global annual growth rate of peritoneal dialysis is estimated to be 8%, which is listed as the preferred method of renal replacement therapy in most countries. Although peritoneal dialysis has been widely used, due to complications such as peritoneal dialysis related infection, peritoneal ultrafiltration failure and EPS, the failure rate of peritoneal dialysis technology is high, and the 3-year technical survival rate is only 64%. Therefore, this study intends to explore clinical strategies for maintaining the long-term peritoneal dialysis by analyzing the clinical characteristics of patients , as well as the differences of risk factors affecting the survival rate of peritoneal dialysis technology at different time stages of peritoneal dialysis treatment.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04034628 -
Improving the Outcomes of Peritoneal Dialysis (PD) Catheter Insertion
|
||
Completed |
NCT03569410 -
The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients
|
N/A | |
Completed |
NCT04302649 -
Dialysate Temperature in Peritoneal Dialysis
|
Phase 4 | |
Enrolling by invitation |
NCT05250752 -
Reduction of Peritoneal Glucose Uptake With Use of SGLT2 in Humans Undergoing Peritoneal Dialysis Treatment
|
Phase 2 | |
Recruiting |
NCT03563898 -
Feasibility and Safety in the Management of Fluid Overload in Peritoneal Dialysis Patients Through Sweat Stimulation With the Use of Portable Sauna Bath, Pilot Study
|
N/A | |
Recruiting |
NCT03046511 -
Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter.
|
Phase 3 | |
Completed |
NCT03458819 -
EMT in Peritoneal Dialysis Patients
|
||
Recruiting |
NCT06398977 -
Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients
|
N/A | |
Not yet recruiting |
NCT06045858 -
SAFETY AND EFFICACY OF APIXABAN VERSUS WARFARIN IN PERITONEAL DIALYSIS PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION: A PROSPECTIVE, RANDOMISED, OPEN-LABEL, BLINDED END-POINT TRIAL (APIDP2)
|
Phase 3 | |
Active, not recruiting |
NCT04034966 -
Utility of Telemedicine in the Follow-Up of Patients in Peritoneal Dialysis
|
N/A | |
Completed |
NCT04923295 -
The Effect of Dapagliflozin on Ultrafiltration Among Peritoneal Dialysis Patients
|
N/A | |
Not yet recruiting |
NCT05715814 -
meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
|
Phase 3 | |
Recruiting |
NCT03148002 -
Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation
|
Phase 4 | |
Recruiting |
NCT04572724 -
The Effect of Sacubitril/Valsartan on Cardiovascular Events in Dialysis Patients and Efficacy Prediction of Baseline LVEF Value
|
Phase 4 | |
Completed |
NCT05797181 -
The Effect Of Medical Nutritional Therapy On Patients With Sarcopenic Obesity Receiving Peritoneal Dialysis Treatment
|
N/A | |
Recruiting |
NCT01893710 -
International (Pediatric) Peritoneal Biobank
|
||
Completed |
NCT03382444 -
The Kidney and The Brain Study - Assessment of Cognitive Impairment in Advanced CKD
|
||
Completed |
NCT04046263 -
Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients
|
Phase 4 | |
Completed |
NCT03759002 -
Association of Mean Platelet Volume and Cardiovascular Disease in Children With End Stage Renal Disease.
|
||
Completed |
NCT04176627 -
Assessing Fluid Status of Peritoneal Dialysis Patients With Assistance of Lung Ultrasound
|